News | December 13, 2021
ICMR Dibrugarh designs kit to detect Omicron variant in two hours
GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model
GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model
Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time
Oravax's vaccine technology is highly scalable for manufacturing and is easily transferable for wide scale logistical distribution, as there is no need for freezer storage
The Omicron variant, which was designated a variant of concern by the World Health Organization (WHO), has more than 30 mutations in the spike protein alone
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The company is a medical dictation solution used by medical practitioners
Subscribe To Our Newsletter & Stay Updated
